Brady Martz Wealth Solutions’s AbbVie ABBV Stock Holding History

Brady Martz Wealth Solutions’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27M	Buy	9,028 +228	+3%	+$49.1K	0.34%	66
2026 Q1	$1.91M	Buy	8,800 +1,525	+21%	+$338K	0.33%	68
2025 Q4	$1.66M	Buy	7,275 +1,272	+21%	+$290K	0.29%	67
2025 Q3	$1.39M	Buy	6,003 +13	+0.2%	+$2.65K	0.25%	73
2025 Q2	$1.11M	Sell	5,990 -33	-0.5%	-$6.13K	0.22%	86
2025 Q1	$1.26M	Buy	6,023 +22	+0.4%	+$4.28K	0.29%	72
2024 Q4	$1.05M	Buy	+6,001	New	+$1.1M	0.25%	80

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Brady Martz Wealth Solutions's ABBV Position: Q2 2026 in Review

Brady Martz Wealth Solutions increased its AbbVie (ABBV) stake by 2.6% in Q2 2026, buying an estimated $49.1K and bringing the position to 9,028 shares worth $2.27M. The position accounts for 0.34% of the portfolio, ranked #66.

Brady Martz Wealth Solutions first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,885 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Brady Martz Wealth Solutions held 9,028 shares of AbbVie worth $2.27M as of Q2 2026.
Brady Martz Wealth Solutions bought 228 AbbVie shares in Q2 2026, an estimated $49.1K.
AbbVie made up 0.34% of Brady Martz Wealth Solutions's portfolio in Q2 2026, its #66 holding.
Brady Martz Wealth Solutions first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
1,885 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brady Martz Wealth Solutions's 13F filing for Q2 2026, filed 23 Jul 2026.